Kanoria Chemicals & Industries Limited (NSE:KANORICHEM)
India · Delayed Price · Currency is INR 96.35
-0.85 (-0.87%)
Jun 3, 2026, 3:17 PM IST
NSE:KANORICHEM Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,814 | 15,367 | 14,751 | 15,784 | 13,691 | |
Revenue Growth (YoY) | -36.13% | 4.18% | -6.55% | 15.29% | 25.05% |
Cost of Revenue | 7,072 | 10,807 | 10,080 | 11,299 | 9,651 |
Gross Profit | 2,742 | 4,560 | 4,671 | 4,485 | 4,040 |
Selling, General & Admin | 584.2 | 2,461 | 2,422 | 2,193 | 2,019 |
Other Operating Expenses | 1,444 | 1,781 | 1,643 | 1,566 | 1,338 |
Operating Expenses | 2,380 | 4,868 | 4,659 | 4,348 | 3,929 |
Operating Income | 361.7 | -307.67 | 11.98 | 137.03 | 110.66 |
Interest Expense | -319.8 | -413.37 | -378.15 | -322.41 | -213.57 |
Interest & Investment Income | - | 5.82 | 3.07 | 1.94 | 4.14 |
Currency Exchange Gain (Loss) | - | 31.97 | -78.23 | -1.28 | 212.6 |
Other Non Operating Income (Expenses) | 224.5 | -31.94 | -21.9 | -76.22 | 3.12 |
EBT Excluding Unusual Items | 266.4 | -715.19 | -463.23 | -260.94 | 116.95 |
Gain (Loss) on Sale of Investments | - | -2.93 | 132.49 | 36.44 | 1.19 |
Gain (Loss) on Sale of Assets | - | 40.02 | 22.8 | 98.21 | 7.87 |
Other Unusual Items | - | -294.44 | - | 4.16 | 5.33 |
Pretax Income | 266.4 | -972.54 | -307.94 | -122.13 | 131.34 |
Income Tax Expense | -57.4 | 117.91 | 209.16 | 6.7 | 109.01 |
Earnings From Continuing Operations | 323.8 | -1,090 | -517.1 | -128.83 | 22.33 |
Earnings From Discontinued Operations | 808.2 | 8.98 | -35.69 | - | - |
Net Income to Company | 1,132 | -1,081 | -552.79 | -128.83 | 22.33 |
Minority Interest in Earnings | 75.8 | 245.5 | 168.83 | 41.17 | 45.93 |
Net Income | 1,208 | -835.97 | -383.96 | -87.66 | 68.26 |
Net Income to Common | 1,208 | -835.97 | -383.96 | -87.66 | 68.26 |
Net Income Growth | - | - | - | - | -53.00% |
Shares Outstanding (Basic) | 44 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 44 | 44 | 44 | 44 | 44 |
Shares Change (YoY) | 0.01% | - | - | - | - |
EPS (Basic) | 27.64 | -19.13 | -8.79 | -2.01 | 1.56 |
EPS (Diluted) | 27.64 | -19.13 | -8.79 | -2.01 | 1.56 |
EPS Growth | - | - | - | - | -53.00% |
Free Cash Flow | 125 | -800.11 | -432.01 | -317.64 | 402.19 |
Free Cash Flow Per Share | 2.86 | -18.31 | -9.89 | -7.27 | 9.21 |
Dividend Per Share | - | - | - | - | 1.000 |
Gross Margin | 27.94% | 29.67% | 31.66% | 28.42% | 29.51% |
Operating Margin | 3.69% | -2.00% | 0.08% | 0.87% | 0.81% |
Profit Margin | 12.31% | -5.44% | -2.60% | -0.56% | 0.50% |
Free Cash Flow Margin | 1.27% | -5.21% | -2.93% | -2.01% | 2.94% |
EBITDA | 713.4 | 298.97 | 587.1 | 713.84 | 664.22 |
EBITDA Margin | 7.27% | 1.95% | 3.98% | 4.52% | 4.85% |
D&A For EBITDA | 351.7 | 606.64 | 575.12 | 576.81 | 553.56 |
EBIT | 361.7 | -307.67 | 11.98 | 137.03 | 110.66 |
EBIT Margin | 3.69% | -2.00% | 0.08% | 0.87% | 0.81% |
Effective Tax Rate | - | - | - | - | 83.00% |
Revenue as Reported | 10,039 | 15,459 | 14,943 | 15,888 | 13,980 |